Loading...
Aclaris Therapeutics, Inc.
ACRS•NASDAQ
HealthcareMedical - Diagnostics & Research
$1.31
$0.07(5.20%)
Aclaris Therapeutics, Inc. (ACRS) Quarterly Earnings Reports & Financial Results
Analyze Aclaris Therapeutics, Inc.’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of Aclaris Therapeutics, Inc.’s actual vs. estimated earnings across recent quarters.
No data available
Aclaris Therapeutics, Inc. (ACRS) Quarterly Earnings Details
Detailed breakdown of Aclaris Therapeutics, Inc.’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.